Pharyngeal Squamous Cell Carcinoma — Trials

Pharyngeal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

297 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 106
Recruiting: 52
Ph III recruiting: 3
Growth YoY: −15%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (51)

clinicaltrialsPublishedShowing 51–69 of 69 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06636734	Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial	recruiting	Phase 2	28	Emory UniversityOTHER	1	Feb 11, 2026	clinicaltrials
NCT05962242	HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma(HN001)	recruiting	Phase 2	90	University of VirginiaOTHER	1	Feb 5, 2026	clinicaltrials